Phase II pethema trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: Efficacy and clinical implications of tumor response kinetics

1. Rosiñol, L.
2. Oriol, A.
3. Mateos, M.V.
4. Sureda, A.
5. García-Sánchez, P.
6. Gutiérrez, N.
7. Alegre, A.
8. Lahuerta, J.J.
9. De La Rubia, J.
10. Herrero, C.
11. Liu, X.
12. Van De Velde, H.
13. San Miguel, J.
14. Bladé, J.